| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 38, 523-531, Copyright © 1983 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
G Bellinghieri, V Savica, A Mallamace, C Di Stefano, F Consolo, LG Spagnoli, S Villaschi, G Palmieri, M Corsi and F Maccari
A group of 14 uremic patients on intermittent hemodialysis was admitted to a cross-over double-blind trial in order to evaluate serum and muscle carnitine levels before and after 60 days of L-carnitine oral (2 g/day) treatment. The morphology of muscle fragments was studied by light and electron microscopy. Symptoms (asthenia, cramps) occurring during hemodialysis were also recorded. After L-carnitine treatment the blood and muscle levels of the metabolite increased simultaneously to reduced asthenia and cramps. Morphological examination of the muscle of 13 of 14 patients did not reveal any pre- or posttreatment pathological alterations. The presence of nemaline rods was morphologically diagnosed in only one case and was no longer observed at the second biopsy at 2 months of L-carnitine treatment.
This article has been cited by other articles:
|
|
 |
|
  L. Vernez, M. Dickenmann, J. Steiger, M. Wenk, and S. Krahenbuhl Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis Nephrol. Dial. Transplant., February 1, 2006; 21(2): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schreiber Levocarnitine and Dialysis: A Review Nutr Clin Pract, April 1, 2005; 20(2): 218 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. CALVANI, P. BENATTI, A. MANCINELLI, S. D'IDDIO, V. GIORDANO, A. KOVERECH, A. AMATO, and E. P. BRASS Carnitine Replacement in End-Stage Renal Disease and Hemodialysis Ann. N.Y. Acad. Sci., November 1, 2004; 1033(1): 52 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. FERRARI, E MERLI, G CICCHITELLI, D MELE, A FUCILI, and C CECONI Therapeutic Effects of l-Carnitine and Propionyl-l-carnitine on Cardiovascular Diseases: A Review Ann. N.Y. Acad. Sci., November 1, 2004; 1033(1): 79 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Hurot, M. Cucherat, M. Haugh, and D. Fouque Effects of L-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review J. Am. Soc. Nephrol., March 1, 2002; 13(3): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khajehdehi, M. Mojerlou, S. Behzadi, and G. A. Rais-Jalali A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1448 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bommer Saving erythropoietin by administering L-carnitine? Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2819 - 2821. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Kopple Pathophysiology of Protein-Energy Wasting in Chronic Renal Failure J. Nutr., January 1, 1999; 129(1): 247S - 247S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Brass and W. R. Hiatt The Role of Carnitine and Carnitine Supplementation During Exercise in Man and in Individuals with Special Needs J. Am. Coll. Nutr., June 1, 1998; 17(3): 207 - 215. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
